ArticleBiomedicines2022

Impact of Bone Metastases on Patients with Renal Cell Carcinoma or Melanoma Treated with Combotherapy Ipilimumab Plus Nivolumab.

Félix Pham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.